STRONG Program for Gastrointestinal Cancer

Phase-Based Progress Estimates
Moffitt Cancer Center, Tampa, FLGastrointestinal CancerConsultations with Moffitt Dietician - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial assesses how well a program providing nutrition support to people fighting gastrointestinal cancer works.

Eligible Conditions
  • Gastrointestinal Cancer

Treatment Effectiveness

Study Objectives

4 Primary · 0 Secondary · Reporting Duration: at 12 weeks

at 12 weeks
Feasibility of the STRONG Program
at 16 weeks
Acceptability of the STRONG Program
Adherence to the STRONG Program
Efficacy of STRONG Program on Treatment Outcomes

Trial Safety

Trial Design

1 Treatment Group

STRONG Program
1 of 1

Experimental Treatment

10 Total Participants · 1 Treatment Group

Primary Treatment: STRONG Program · No Placebo Group · N/A

STRONG ProgramExperimental Group · 3 Interventions: Consultations with Moffitt Dietician, Daily Food Intake Diary with Fitbit smartphone application, Questionnaires · Intervention Types: Behavioral, Behavioral, Behavioral
First Studied
Drug Approval Stage
How many patients have taken this drug
Completed Phase 2

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: at 12 weeks

Who is running the clinical trial?

H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor
510 Previous Clinical Trials
126,942 Total Patients Enrolled
Ben Powers, MDPrincipal InvestigatorMoffitt Cancer Center
Kea Turner, PhDPrincipal InvestigatorMoffitt Cancer Center
2 Previous Clinical Trials
100 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Are there any unfilled positions for participants in this experiment?

"As indicated on, this medical experiment is still actively seeking participants and was initially posted to the website on December 1st 2022 with its last update occurring 6 days later." - Anonymous Online Contributor

Unverified Answer

How many patients is this trial accommodating?

"Affirmative. According to, this study is currently accepting participants and was first publicized on December 1st 2022. The most recent update occurred on the 6th of that same month. 10 patients from a single site need to be recruited for successful completion of the trial." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.